4 articles tagged
Once a booming sector, life sciences real estate is now facing record-high vacancy rates of 27%, driven by cuts in federal funding and a retreat in venture capital.
Alexandria Real Estate Equities is leveraging the stability of its pharmaceutical and biotech tenants to navigate market challenges, supported by a 6.3% yield.
Eli Lilly and Alexandria Real Estate Equities have launched an 82,514-square-foot biotech innovation hub in San Diego to support early-stage companies.
Alexandria Real Estate Equities and Eli Lilly have launched a new Lilly Gateway Labs in San Diego to provide lab space and support for biotech startups.
